Selected research
Market Structure
Global Apixaban Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Apixaban market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Apixaban is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Apixaban is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Apixaban is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Apixaban is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Apixaban include Pfizer, Polpharma, Medichem, Dipharma Francis, DEAFARMA, Centaur Pharmaceutical and Beijing Cooperate Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Apixaban market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Apixaban and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Apixaban sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Apixaban market size, projected growth trends, production technologies, key applications, and end-use industries.
Apixaban Segment by Company
Pfizer
Polpharma
Medichem
Dipharma Francis
DEAFARMA
Centaur Pharmaceutical
Beijing Cooperate Pharmaceutical
Apixaban Segment by Type
Capsule Apixaban
Tablet Apixaban
Apixaban Segment by Application
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Apixaban Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Apixaban market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Apixaban and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Apixaban.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Apixaban market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Apixaban manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Apixaban in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Apixaban in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Capsule Apixaban
- Tablet Apixaban
Applications
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Companies covered
- Pfizer
- Polpharma
- Medichem
- Dipharma Francis
- DEAFARMA
- Centaur Pharmaceutical
- Beijing Cooperate Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Apixaban Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Apixaban Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Apixaban Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Apixaban Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Apixaban Market Dynamics
- 2.1 Apixaban Industry Trends
- 2.2 Apixaban Industry Drivers
- 2.3 Apixaban Industry Opportunities and Challenges
- 2.4 Apixaban Industry Restraints
3 Apixaban Market by Manufacturers
- 3.1 Global Apixaban Revenue by Manufacturers (2021-2026)
- 3.2 Global Apixaban Sales by Manufacturers (2021-2026)
- 3.3 Global Apixaban Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Apixaban Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Apixaban Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Apixaban Manufacturers, Product Type & Application
- 3.7 Global Apixaban Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Apixaban Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Apixaban Players Market Share by Revenue in 2025
- 3.8.3 2025 Apixaban Tier 1, Tier 2, and Tier 3
4 Apixaban Market by Type
- 4.1 Apixaban Type Introduction
- 4.1.1 Capsule Apixaban
- 4.1.2 Tablet Apixaban
- 4.2 Global Apixaban Sales by Type
- 4.2.1 Global Apixaban Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Apixaban Sales by Type (2021-2032)
- 4.2.3 Global Apixaban Sales Market Share by Type (2021-2032)
- 4.3 Global Apixaban Revenue by Type
- 4.3.1 Global Apixaban Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Apixaban Revenue by Type (2021-2032)
- 4.3.3 Global Apixaban Revenue Market Share by Type (2021-2032)
5 Apixaban Market by Application
- 5.1 Apixaban Application Introduction
- 5.1.1 Hospital Pharmacy
- 5.1.2 Online Pharmacy
- 5.1.3 Retail Pharmacy
- 5.2 Global Apixaban Sales by Application
- 5.2.1 Global Apixaban Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Apixaban Sales by Application (2021-2032)
- 5.2.3 Global Apixaban Sales Market Share by Application (2021-2032)
- 5.3 Global Apixaban Revenue by Application
- 5.3.1 Global Apixaban Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Apixaban Revenue by Application (2021-2032)
- 5.3.3 Global Apixaban Revenue Market Share by Application (2021-2032)
6 Global Apixaban Sales by Region
- 6.1 Global Apixaban Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Apixaban Sales by Region (2021-2032)
- 6.2.1 Global Apixaban Sales by Region (2021-2026)
- 6.2.2 Global Apixaban Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Apixaban Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Apixaban Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Apixaban Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Apixaban Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Apixaban Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Apixaban Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Apixaban Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Apixaban Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Apixaban Revenue by Region
- 7.1 Global Apixaban Revenue by Region
- 7.1.1 Global Apixaban Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Apixaban Revenue by Region (2021-2026)
- 7.1.3 Global Apixaban Revenue by Region (2027-2032)
- 7.1.4 Global Apixaban Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Apixaban Revenue (2021-2032)
- 7.2.2 North America Apixaban Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Apixaban Revenue (2021-2032)
- 7.3.2 Europe Apixaban Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Apixaban Revenue (2021-2032)
- 7.4.2 Asia-Pacific Apixaban Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Apixaban Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Apixaban Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Pfizer
- 8.1.1 Pfizer Company Information
- 8.1.2 Pfizer Business Overview
- 8.1.3 Pfizer Apixaban Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Pfizer Apixaban Product Portfolio
- 8.1.5 Pfizer Recent Developments
- 8.2 Polpharma
- 8.2.1 Polpharma Company Information
- 8.2.2 Polpharma Business Overview
- 8.2.3 Polpharma Apixaban Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Polpharma Apixaban Product Portfolio
- 8.2.5 Polpharma Recent Developments
- 8.3 Medichem
- 8.3.1 Medichem Company Information
- 8.3.2 Medichem Business Overview
- 8.3.3 Medichem Apixaban Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Medichem Apixaban Product Portfolio
- 8.3.5 Medichem Recent Developments
- 8.4 Dipharma Francis
- 8.4.1 Dipharma Francis Company Information
- 8.4.2 Dipharma Francis Business Overview
- 8.4.3 Dipharma Francis Apixaban Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Dipharma Francis Apixaban Product Portfolio
- 8.4.5 Dipharma Francis Recent Developments
- 8.5 DEAFARMA
- 8.5.1 DEAFARMA Company Information
- 8.5.2 DEAFARMA Business Overview
- 8.5.3 DEAFARMA Apixaban Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 DEAFARMA Apixaban Product Portfolio
- 8.5.5 DEAFARMA Recent Developments
- 8.6 Centaur Pharmaceutical
- 8.6.1 Centaur Pharmaceutical Company Information
- 8.6.2 Centaur Pharmaceutical Business Overview
- 8.6.3 Centaur Pharmaceutical Apixaban Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Centaur Pharmaceutical Apixaban Product Portfolio
- 8.6.5 Centaur Pharmaceutical Recent Developments
- 8.7 Beijing Cooperate Pharmaceutical
- 8.7.1 Beijing Cooperate Pharmaceutical Company Information
- 8.7.2 Beijing Cooperate Pharmaceutical Business Overview
- 8.7.3 Beijing Cooperate Pharmaceutical Apixaban Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Beijing Cooperate Pharmaceutical Apixaban Product Portfolio
- 8.7.5 Beijing Cooperate Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Apixaban Value Chain Analysis
- 9.1.1 Apixaban Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Apixaban Production Mode & Process
- 9.2 Apixaban Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Apixaban Distributors
- 9.2.3 Apixaban Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst